Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Soleno Therapeutics Inc shares valued at $265,156 were sold by Hirano Patricia C on Apr 01 ’25. At $70.11 per share, Hirano Patricia C sold 3,782 shares. The insider’s holdings dropped to 27,036 shares worth approximately $2.14 million following the completion of this transaction.
Also, PATRICIA HIRANO purchased 3,782 shares, netting a total of over 265,156 in proceeds.
Before that, Pauls Matthew had sold 5,937 shares from its account. In a trade valued at $424,797, the Director traded Soleno Therapeutics Inc shares for $71.55 each. Upon closing the transaction, the insider’s holdings decreased to 5,937 shares, worth approximately $0.51 million.
Analysts at Stifel resumed the stock at ‘”a Buy”‘ outlook in a report released in early December. As of December 02, 2024, Robert W. Baird has reiterated its “an Outperform” rating for SLNO. Earlier on September 03, 2024, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for SLNO stock.
Analyzing SLNO Stock Performance
During the last five days, there has been a surge of approximately 2.74%. Over the course of the year, Soleno Therapeutics Inc shares have jumped approximately 76.08%. Shares of the company reached a 52-week high of $80.99 on 05/08/25 and a 52-week low of $41.50 on 01/15/25.
Support And Resistance Levels for Soleno Therapeutics Inc (SLNO)
According to the 24-hour chart, there is a support level at 78.67, which, if violated, would cause prices to drop to 78.19. In the upper region, resistance lies at 79.91. The next price resistance is at 80.67. RSI (Relative Strength Index) is 61.45 on the 14-day chart, showing neutral technical sentiment.
